Sandoz Group (OTCMKTS:SDZNY) Shares Up 1% – Here’s Why

Sandoz Group AG (OTCMKTS:SDZNY) traded up 1% on Thursday . The company traded as high as $42.49 and last traded at $41.71. 19,907 shares traded hands during trading, a decline of 79% from the average session volume of 92,822 shares. The stock had previously closed at $41.31.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the company. Royal Bank of Canada cut Sandoz Group from a “moderate buy” rating to a “hold” rating in a research note on Monday, September 16th. BNP Paribas downgraded Sandoz Group from a “strong-buy” rating to a “hold” rating in a research report on Monday, December 2nd.

Sandoz Group Stock Performance

The company has a 50 day simple moving average of $44.02 and a 200 day simple moving average of $41.68.

Sandoz Group Company Profile

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.